Renal pelvis inverted papilloma

Summary

Renal pelvis inverted papilloma (MONDO:0003776) is a disease. A subtype of renal pelvis urothelial papilloma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	renal pelvis inverted papilloma
Mondo ID	MONDO:0003776
DOID	DOID:6118
NCIT	C6187
UMLS	C1335751
MedGen	277591
Anatomy (UBERON)	UBERON:0001224
Is cancer (heuristic)	no

Also known as: inverted papilloma of kidney pelvis · inverted papilloma of renal pelvis · inverted papilloma of the kidney pelvis · inverted papilloma of the renal pelvis · kidney pelvis inverted papilloma · renal pelvis inverted papilloma

Disease family

This is a subtype of renal pelvis urothelial papilloma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › papillary epithelial neoplasm › papillary urothelial neoplasm › renal pelvis papillary tumor › renal pelvis urothelial papilloma › renal pelvis inverted papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.